Skip to main content
Clinical Trials/IRCT20190730044380N1
IRCT20190730044380N1
Completed
Phase 3

Evaluation of the effect of misoprostol with and without letrozole as premedication on induction of abortion in pregnant women with missed abortion at their first trimester of pregnancy

Esfahan University of Medical Sciences0 sites126 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
126
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1:Gestational age less than 12 week(confirmed with ultrasonogarphy)
  • patient with missed abortion (confirmed with ultrasonography)
  • acceptance of participant
  • patient age above 18 years old
  • hemoglobin above 12

Exclusion Criteria

  • Clinical manifestation or history of adrenal gland impairment
  • History of any malignancy
  • History or clinical evidence of any thromboembolic impairment
  • History of hepatic or renal diseases
  • History of cardiovascular disease that prescription of misoprostol or letrozol forbidden based on cardiologist opinion.
  • History of use corticosteroid
  • Present of classic scar or t shape scar on the uterus
  • Impairment of coagulation test

Outcomes

Primary Outcomes

Not specified

Similar Trials